NASDAQ:KPRX

Kiora Pharmaceuticals Stock Insider Trading

etoro logo Buy KPRX
*Your capital is at risk
$2.68
-0.0400 (-1.47%)
At Close: Jun 03, 2026

Kiora Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 98.01. In total, the insiders bought 1.78M and sold 4.24K KPRX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
98.01
Buy 1.78M shares
Sell 4.24K shares
95% Buy Activity
Weak Negative Correlation
Sell Signal Low Confidence
Apr 01, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 98.01.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Apr 01, 2026
Sell
Common Stock
F-InKind
Tosca Melissa
CFO
C-Suite Officer 929
Value: $2K
Apr 01, 2026
Sell
Common Stock
F-InKind
Daniels Eric Joseph
Chief Development Officer
Officer 929
Value: $2K
Apr 01, 2026
Sell
Common Stock
F-InKind
Strem Brian M.
President And CEO
CEO / President 1 906
Value: $4K
Mar 06, 2026
Buy
Common Stock
A-Award
Tosca Melissa
CFO
C-Suite Officer 6 533
Value: $12.9K
Mar 06, 2026
Buy
Stock Option (right to buy)
A-Award
Strem Brian M.
President And CEO
CEO / President 33 467
Value: $66.3K
Mar 06, 2026
Buy
Common Stock
A-Award
Strem Brian M.
President And CEO
CEO / President 16 733
Value: $33.1K
Mar 06, 2026
Buy
Stock Option (right to buy)
A-Award
Daniels Eric Joseph
Chief Development Officer
Officer 13 067
Value: $25.9K
Mar 06, 2026
Buy
Common Stock
A-Award
Daniels Eric Joseph
Chief Development Officer
Officer 6 533
Value: $12.9K
Mar 06, 2026
Buy
Stock Option (right to buy)
A-Award
Tosca Melissa
CFO
C-Suite Officer 13 067
Value: $25.9K
Mar 03, 2026
Sell
Common Stock
F-InKind
Strem Brian M.
President And CEO
CEO / President 238
Value: $481
Mar 03, 2026
Sell
Common Stock
F-InKind
Daniels Eric Joseph
Chief Development Officer
Officer 238
Value: $481
Apr 01, 2025
Buy
Common Stock
A-Award
Tosca Melissa
CFO
C-Suite Officer 7 772
Value: $22.8K
Apr 01, 2025
Buy
Stock Option (right to buy)
A-Award
Tosca Melissa
CFO
C-Suite Officer 15 543
Value: $45.5K
Apr 01, 2025
Buy
Common Stock
A-Award
Daniels Eric Joseph
Chief Development Officer
Officer 7 772
Value: $22.8K
Apr 01, 2025
Buy
Stock Option (right to buy)
A-Award
Daniels Eric Joseph
Chief Development Officer
Officer 15 543
Value: $45.5K
Apr 01, 2025
Buy
Common Stock
A-Award
Strem Brian M.
President And CEO
CEO / President 15 941
Value: $46.7K
Apr 01, 2025
Buy
Stock Option (right to buy)
A-Award
Strem Brian M.
President And CEO
CEO / President 31 883
Value: $93.4K
Apr 01, 2025
Buy
Stock Option (right to buy)
A-Award
Shapiro Aron
Director
Director 20 000
Value: $58.6K
Apr 01, 2025
Buy
Stock Option (right to buy)
A-Award
Parsons Erin
Director
Director 20 000
Value: $58.6K
Apr 01, 2025
Buy
Stock Option (right to buy)
A-Award
Hollander David
Director
Director 20 000
Value: $58.6K
Apr 01, 2025
Buy
Stock Option (right to buy)
A-Award
Tyle Praveen
Director
Director 30 000
Value: $87.9K
Apr 01, 2025
Buy
Stock Option (right to buy)
A-Award
Stengone Carmine N.
Director
Director 20 000
Value: $58.6K
Apr 01, 2025
Buy
Stock Option (right to buy)
A-Award
Walters-hoffert Lisa
Director
Director 20 000
Value: $58.6K
Apr 01, 2025
Buy
Stock Option (right to buy)
A-Award
Walters-hoffert Lisa
Director
Director 20 000
Value: $58.6K
Apr 01, 2025
Buy
Stock Option (right to buy)
A-Award
Stengone Carmine N.
Director
Director 20 000
Value: $58.6K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT KIORA PHARMACEUTICALS, INC.
Kiora Pharmaceuticals
Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, develops and commercializes therapies for the treatment of ophthalmic diseases in the United States. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 1 clinical trial that acts as a photoswitch to restore vision in patients with inherited and age-related degenerative retinal diseases. The company is also developing KIO-101, a...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE